Press Release
Premier Research Institute Launches India's Fir...
Kozhikode: The Council for Scientific and Industrial Research (CSIR) today launched the country's first anti-diabetic ayurvedic drug for type two Diabetes mellitus. The drug BGR-34 is developed jointly by National...
Premier Research Institute Launches India's Fir...
Kozhikode: The Council for Scientific and Industrial Research (CSIR) today launched the country's first anti-diabetic ayurvedic drug for type two Diabetes mellitus. The drug BGR-34 is developed jointly by National...
BGR-34 – An herbal drug for diabetes in Hyderabad
A Council of Scientific and Industrial Research (CSIR) lab in Lucknow has launched an anti-diabetes herbal drug called BGR-34. The drug is a scientifically validated one and has been launched...
BGR-34 – An herbal drug for diabetes in Hyderabad
A Council of Scientific and Industrial Research (CSIR) lab in Lucknow has launched an anti-diabetes herbal drug called BGR-34. The drug is a scientifically validated one and has been launched...
Low cost Ayurvedic medicine for diabetes launch...
A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has...
Low cost Ayurvedic medicine for diabetes launch...
A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has...
BGR-34 launched in Punjab, newspaper coverage
Senior scientists of the Council for Scientific and Industrial Research, the National Botanical Research Institute and the Central Institute for Medicinal and Aromatic Plants launch the anti-diabetic drug, BGR-34, in...
BGR-34 launched in Punjab, newspaper coverage
Senior scientists of the Council for Scientific and Industrial Research, the National Botanical Research Institute and the Central Institute for Medicinal and Aromatic Plants launch the anti-diabetic drug, BGR-34, in...